Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Return on Equity (2016 - 2026)

Avanos Medical's Return on Equity history spans 12 years, with the latest figure at 0.01% for Q3 2025.

  • On a quarterly basis, Return on Equity fell 1.0% to 0.01% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.01%, a 1.0% decrease, with the full-year FY2024 number at 0.0%, changed 0.0% from a year prior.
  • Return on Equity hit 0.01% in Q3 2025 for Avanos Medical, down from 0.0% in the prior quarter.
  • Over the last five years, Return on Equity for AVNS hit a ceiling of 0.0% in Q4 2022 and a floor of 0.01% in Q3 2025.
  • Historically, Return on Equity has averaged 0.0% across 5 years, with a median of 0.0% in 2021.
  • Biggest five-year swings in Return on Equity: changed 0bps in 2021 and later decreased -1bps in 2025.
  • Tracing AVNS's Return on Equity over 5 years: stood at 0.0% in 2021, then skyrocketed by 180bps to 0.0% in 2022, then crashed by -316bps to 0.0% in 2023, then skyrocketed by 87bps to 0.0% in 2024, then plummeted by -13207bps to 0.01% in 2025.
  • Business Quant data shows Return on Equity for AVNS at 0.01% in Q3 2025, 0.0% in Q2 2025, and 0.0% in Q1 2025.